Smith, Graham & Co., Investment Advisors, LP Eagle Pharmaceuticals, Inc. Transaction History

Smith, Graham & Co., Investment Advisors, LP

$867 Million
Q4 2023

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$15.21 - $22.88 $55,486 - $83,466	3,648 Added 1.35%	273,099 $4.31 Million
Q2 2023 Jul 31, 2023	BUY	$17.74 - $31.87 $577,756 - $1.04 Million	32,568 Added 13.75%	269,451 $5.24 Million
Q1 2023 May 09, 2023	BUY	$25.06 - $34.09 $141,864 - $192,983	5,661 Added 2.45%	236,883 $6.72 Million
Q4 2022 Feb 02, 2023	SELL	$24.98 - $39.77 $19,959 - $31,776	-799 Reduced 0.34%	231,222 $6.76 Million
Q3 2022 Nov 04, 2022	SELL	$26.42 - $47.12 $8,507 - $15,172	-322 Reduced 0.14%	232,021 $6.13 Million
Q2 2022 Aug 04, 2022	SELL	$41.26 - $51.35 $98,075 - $122,058	-2,377 Reduced 1.01%	232,343 $10.3 Million
Q1 2022 May 06, 2022	SELL	$44.58 - $52.6 $68,251 - $80,530	-1,531 Reduced 0.65%	234,720 $11.6 Million
Q4 2021 Jan 26, 2022	SELL	$45.82 - $56.9 $883,455 - $1.1 Million	-19,281 Reduced 7.55%	236,251 $12 Million
Q3 2021 Nov 01, 2021	SELL	$43.79 - $55.78 $965,131 - $1.23 Million	-22,040 Reduced 7.94%	255,532 $14.3 Million
Q2 2021 Aug 09, 2021	SELL	$36.86 - $44.5 $1.3 Million - $1.56 Million	-35,145 Reduced 11.24%	277,572 $11.9 Million
Q1 2021 Apr 27, 2021	BUY	$40.32 - $50.97 $5.17 Million - $6.54 Million	128,293 Added 69.56%	312,717 $13.1 Million
Q4 2020 Jan 20, 2021	SELL	$41.72 - $51.34 $140,763 - $173,221	-3,374 Reduced 1.8%	184,424 $8.59 Million
Q3 2020 Oct 27, 2020	BUY	$37.02 - $51.28 $1.08 Million - $1.49 Million	29,127 Added 18.36%	187,798 $7.98 Million
Q2 2020 Jul 21, 2020	BUY	$43.24 - $55.02 $329,834 - $419,692	7,628 Added 5.05%	158,671 $7.61 Million
Q1 2020 Apr 23, 2020	BUY	$34.37 - $60.07 $379,066 - $662,512	11,029 Added 7.88%	151,043 $6.95 Million
Q4 2019 Jan 21, 2020	SELL	$54.32 - $64.31 $795,244 - $941,498	-14,640 Reduced 9.47%	140,014 $8.41 Million
Q3 2019 Oct 18, 2019	BUY	$53.25 - $59.98 $52,185 - $58,780	980 Added 0.64%	154,654 $8.75 Million
Q2 2019 Jul 30, 2019	BUY	$46.61 - $58.45 $3.02 Million - $3.79 Million	64,890 Added 73.09%	153,674 $8.56 Million
Q1 2019 Apr 23, 2019	BUY	$38.66 - $51.82 $3.43 Million - $4.6 Million	88,784 New	88,784 $4.48 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Graham & Co., Investment Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Smith, Graham & Co., Investment Advisors, LP with notifications on news.

Account